Assessing the Benefit of Dietary Choline Supplementation Throughout Adulthood in the Ts65Dn Mouse Model of Down Syndrome
Authors:
- Savannah TallinoSTSavannah Tallino
- Rachel EtebariRERachel Etebari
- Ian McDonoughIMIan McDonough
- Hector LeonHLHector Leon
- Isabella SepulvedaISIsabella Sepulveda
- Wendy WinslowWWWendy Winslow
- Samantha K. BartholomewSBSamantha K. Bartholomew
- Sylvia E. PerezSylvia E. Perez
- Elliott J. MufsonEMElliott J. Mufson
- Ramon VelazquezRVRamon Velazquez
Open Access
- 30 November 2024
- Vol. 16 (23) , 4167
Abstract
Background/Objectives: Down syndrome (DS) is the most common cause of early-onset Alzheimer’s disease (AD). Dietary choline has been proposed as a modifiable factor to improve the cognitive and pathological outcomes of AD and DS, especially as many do not reach adequate daily intake levels of choline. While lower circulating choline levels correlate with worse pathological measures in AD patients, choline status and intake in DS is widely understudied. Perinatal choline supplementation (Ch+) in the Ts65Dn mouse model of DS protects offspring against AD-relevant pathology and improves cognition. Further, dietary Ch+ in adult AD models also ameliorates pathology and improves cognition. However, dietary Ch+ in adult Ts65Dn mice has not yet been explored; thus, this study aimed to supply Ch+ throughout adulthood to determine the effects on cognition and DS co-morbidities. Methods: We fed trisomic Ts65Dn mice and disomic littermate controls either a choline normal (ChN; 1.1 g/kg) or a Ch+ (5 g/kg) diet from 4.5 to 14 months of age. Results: We found that Ch+ in adulthood failed to improve genotype-specific deficits in spatial learning. However, in both genotypes of female mice, Ch+ significantly improved cognitive flexibility in a reverse place preference task in the IntelliCage behavioral phenotyping system. Further, Ch+ significantly reduced weight gain and peripheral inflammation in female mice of both genotypes, and significantly improved glucose metabolism in male mice of both genotypes. Conclusions: Our findings suggest that adulthood choline supplementation benefits behavioral and biological factors important for general well-being in DS and related to AD risk.Keywords
Funding Information
- National Institute on Aging (R01AG059627)
This publication has 111 references indexed in Scilit:
- Liver integrity and the risk of Alzheimer's disease and related dementiasAlzheimer's & Dementia, 2023
- Basal forebrain atrophy along the Alzheimer's disease continuum in adults with Down syndromeAlzheimer's & Dementia, 2023
- Cardiometabolic risk in young adults with Down syndromeAmerican Journal of Medical Genetics Part A, 2023
- Cardiometabolic profiles in children and adults with overweight and obesity and down syndromeAmerican Journal of Medical Genetics Part A, 2022
- Further understanding the connection between Alzheimer's disease and Down syndromeAlzheimer's & Dementia, 2020
- Choline Supplementation Ameliorates Behavioral Deficits and Alzheimer's Disease‐Like Pathology in Transgenic APP/PS1 MiceMolecular Nutrition & Food Research, 2019
- Maternal Choline Supplementation Alters Basal Forebrain Cholinergic Neuron Gene Expression in the Ts65Dn Mouse Model of Down SyndromeDevelopmental Neurobiology, 2019
- CA1 pyramidal neuron gene expression mosaics in the Ts65Dn murine model of Down syndrome and Alzheimer's disease following maternal choline supplementationHippocampus, 2018
- Blood biomarkers of methylation in Down syndrome and metabolic simulations using a mathematical modelMolecular Nutrition & Food Research, 2012
- Decreased Brain Choline Uptake in Older AdultsJAMA, 1995